Skip to content

Tepid sponging and dipyrone versus dipyrone alone for reduction of body temperature in febrile children

Tepid sponging and dipyrone versus dipyrone alone for reduction of body temperature in febrile children - a clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12608000083392
Enrollment
120
Registered
2008-02-14
Start date
2007-12-21
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The role of tepid sponging to promote fever control in children is controversial. We did not find studies reporting the effectiveness of tepid sponging in addition to dipyrone. The aim of this study is to compare the effects of tepid sponging plus dipyrone with dipyrone alone in reducing fever. This randomized clinical trial will take place at Instituto Materno-Infantil Professor Fernando Figueira, Teaching Hospital, Recife, Pernambuco. Children from 6 months to 5 years old with axillary temperature > 38 C in the emergency ward between January and July 2006 are eligible. One hundred-twenty children will be randomly assigned to receive oral dipyrone (20 mg/Kg) or oral dipyrone and tepid sponging during 15’. The primary outcome is the mean temperature reduction after 15, 30, 60, 90 and 120 minutes. Secondary outcomes are crying and irritability.

Interventions

Dipyrone (20 mg/Kg) oral syrup by mouth at the beginning of the study and tepid sponging during 15 minutes

Sponsors

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
Lead SponsorGovernment body

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
6 Months to 60 Months
Healthy volunteers
No

Inclusion criteria

Children attended between 5:00 h p.m and 7:00 h p.m. and aged from 6 to 60 months with an axillary temperature of between 38.5 C and 40 C and a clinical diagnosis consistent with upper respiratory tract infections (URTI). Able to stay in the emergency ward for at least two hours.

Exclusion criteria

Requiring admission, urgent investigation or emergency treatment and those who had received antipyretic, steroids or non-steroidal anti-inflammatory drugs (NSAIDs) during the previous six hours were excluded, as where children with known liver or renal diseases, gastrointestinal bleeding, known allergy to dipyrone, congenital or acquired immunodeficiency or malignancy

Outcome results

None listed

Source: ANZCTR · Data processed: Apr 5, 2026